Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Fresh Tracks Therapeutics Inc
Bullboard Posts
User Avatar Image
(45)
•••
Comment by Huntamun1234on Jun 21, 2017 12:16pm
190 Views
Post# 26388024

RE:RE:RE:RE:RE:RE:RE:RE:RE:Righand - Explain it to me like im 5 - 2

RE:RE:RE:RE:RE:RE:RE:RE:RE:Righand - Explain it to me like im 5 - 2I hope you didn't have gnats like RH2 on your camping trip. You seem like you're irate, but ur buddy LK appears to be a good boy. Peace bra!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities